Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Vector and Chemoprevention-based Interventions to Reduce Malaria Burden in Urban Daaras of Touba, Senegal

NCT06225297 is registered in ClinicalTrials.gov with PATH as lead sponsor.

NCT NCT06225297
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06225297 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Vector and Chemoprevention-based Interventions to Reduce Malaria Burden in Urban Daaras of Touba, Senegal
Lead sponsor
PATH
Phase
Phase 4
Overall status
Suspended
Start date
January 19, 2024
Completion date
February 28, 2025
Enrollment
4,600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria